Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2022 Filed Sep 7, 2022 00:52 UTC |
Sanford Bart BenEVP, Operations
|
Tax withholdingCommon Stock | 318 | $28.78 | $9,152.04 |
DisclosureSEC source: 0001209191-22-048925 · doc4.xml · nonDerivative · entry 2 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,206 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2022. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:52 UTC |
Sanford Bart BenEVP, Operations
|
Exercise / conversionCommon Stock | 508 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-048925 · doc4.xml · nonDerivative · entry 1 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:52 UTC |
Parr George JChief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-048924 · doc4.xml · derivative · entry 3 Parr George J · CIK 0001722045 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,385 Underlying: Common Stock · 1,126 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on June 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on June 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:52 UTC |
Parr George JChief Commercial Officer
|
Tax withholdingCommon Stock | 499 | $28.78 | $14,361.22 |
DisclosureSEC source: 0001209191-22-048924 · doc4.xml · nonDerivative · entry 2 Parr George J · CIK 0001722045 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,135 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2022. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:52 UTC |
Parr George JChief Commercial Officer
|
Exercise / conversionCommon Stock | 1,126 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-048924 · doc4.xml · nonDerivative · entry 1 Parr George J · CIK 0001722045 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,634 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:51 UTC |
Shabshab NabilDirector · CEO and President
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-048923 · doc4.xml · derivative · entry 4 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,702 Underlying: Common Stock · 2,117 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:51 UTC |
Shabshab NabilDirector · CEO and President
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-048923 · doc4.xml · derivative · entry 3 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,978 Underlying: Common Stock · 1,568 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. F3 · derivative.expiration_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:51 UTC |
Shabshab NabilDirector · CEO and President
|
Tax withholdingCommon Stock | 1,828 | $28.78 | $52,609.84 |
DisclosureSEC source: 0001209191-22-048923 · doc4.xml · nonDerivative · entry 2 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,369 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2022. Read SEC document |
| September 01, 2022 Filed Sep 7, 2022 00:51 UTC |
Shabshab NabilDirector · CEO and President
|
Exercise / conversionCommon Stock | 3,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-048923 · doc4.xml · nonDerivative · entry 1 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,197 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 17:48 UTC |
Miranda KristenDirector
|
GrantCommon Stock | 6,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-036058 · doc4.xml · nonDerivative · entry 1 Miranda Kristen · CIK 0001846408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,738 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 17:42 UTC |
Boehnlein Glenn SDirector
|
GrantCommon Stock | 6,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-036046 · doc4.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,308 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 21:50 UTC |
Rider Heather D.Director
|
GrantCommon Stock | 6,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-036063 · doc4.xml · nonDerivative · entry 1 Rider Heather D. · CIK 0001616363 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,624 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 21:49 UTC |
Mora ElizabethDirector
|
GrantCommon Stock | 6,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-036061 · doc4.xml · nonDerivative · entry 1 Mora Elizabeth · CIK 0001548935 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,603 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 21:43 UTC |
King Kevin MDirector
|
GrantCommon Stock | 6,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-036049 · doc4.xml · nonDerivative · entry 1 King Kevin M · CIK 0001385014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,308 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 21:44 UTC |
Ladone Mary KayDirector
|
GrantCommon Stock | 6,849 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-036052 · doc4.xml · nonDerivative · entry 1 Ladone Mary Kay · CIK 0001760737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,308 F1 · shares: The reported shares were acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) the one-year anniversary of the date of grant, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting date. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:46 UTC |
Parr George JChief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 4,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034376 · doc4.xml · derivative · entry 3 Parr George J · CIK 0001722045 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,511 Underlying: Common Stock · 4,504 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:46 UTC |
Parr George JChief Commercial Officer
|
Tax withholdingCommon Stock | 1,996 | $25.91 | $51,716.36 |
DisclosureSEC source: 0001209191-22-034376 · doc4.xml · nonDerivative · entry 2 Parr George J · CIK 0001722045 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,508 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:46 UTC |
Parr George JChief Commercial Officer
|
Exercise / conversionCommon Stock | 4,504 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034376 · doc4.xml · nonDerivative · entry 1 Parr George J · CIK 0001722045 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,504 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:44 UTC |
Sanford Bart BenEVP, Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 235 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034375 · doc4.xml · derivative · entry 4 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,587 Underlying: Common Stock · 235 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:44 UTC |
Sanford Bart BenEVP, Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 273 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034375 · doc4.xml · derivative · entry 3 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,911 Underlying: Common Stock · 273 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:44 UTC |
Sanford Bart BenEVP, Operations
|
Tax withholdingCommon Stock | 318 | $25.91 | $8,239.38 |
DisclosureSEC source: 0001209191-22-034375 · doc4.xml · nonDerivative · entry 2 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,016 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:44 UTC |
Sanford Bart BenEVP, Operations
|
Exercise / conversionCommon Stock | 508 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034375 · doc4.xml · nonDerivative · entry 1 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:42 UTC |
Shabshab NabilDirector · CEO and President
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,117 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034374 · doc4.xml · derivative · entry 4 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,819 Underlying: Common Stock · 2,117 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 50% of the restricted stock units will vest on March 1, 2022, and the remaining 50% of the restricted stock units will vest in 1/8th quarterly installments over the following 2 years. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:42 UTC |
Shabshab NabilDirector · CEO and President
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034374 · doc4.xml · derivative · entry 3 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,546 Underlying: Common Stock · 1,568 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. F3 · derivative.expiration_date: Subject to the reporting person's continued service with the Company, 25% of the restricted stock units will vest March 1, 2022, and the remaining 75% of the restricted stock units will vest in 1/12th quarterly installments over the following 3 years. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:42 UTC |
Shabshab NabilDirector · CEO and President
|
Tax withholdingCommon Stock | 1,828 | $25.91 | $47,363.48 |
DisclosureSEC source: 0001209191-22-034374 · doc4.xml · nonDerivative · entry 2 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,512 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 23:42 UTC |
Shabshab NabilDirector · CEO and President
|
Exercise / conversionCommon Stock | 3,685 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034374 · doc4.xml · nonDerivative · entry 1 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,340 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2022 Filed May 12, 2022 18:24 UTC |
Caltrider Kristin A.EVP, CFO and Treasurer
|
GrantRestricted Stock Unit · Derivative | 12,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028623 · doc4.xml · derivative · entry 1 Caltrider Kristin A. · CIK 0001915385 · EVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,510 Underlying: Common Stock · 12,510 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. F2 · derivative.expiration_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. Read SEC document |
| May 10, 2022 Filed May 12, 2022 22:25 UTC |
Parr George JChief Commercial Officer
|
GrantRestricted Stock Unit · Derivative | 39,021 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028625 · doc4.xml · derivative · entry 1 Parr George J · CIK 0001722045 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,021 Underlying: Common Stock · 39,021 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. F2 · derivative.expiration_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. Read SEC document |
| May 10, 2022 Filed May 12, 2022 22:28 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
GrantRestricted Stock Unit · Derivative | 19,276 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028630 · doc4.xml · derivative · entry 1 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,276 Underlying: Common Stock · 19,276 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. F2 · derivative.expiration_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. Read SEC document |
| May 10, 2022 Filed May 12, 2022 22:27 UTC |
Shabshab NabilDirector · CEO and President
|
GrantRestricted Stock Unit · Derivative | 109,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028628 · doc4.xml · derivative · entry 1 Shabshab Nabil · CIK 0001568903 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,531 Underlying: Common Stock · 109,531 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. F2 · derivative.expiration_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. Read SEC document |
| May 10, 2022 Filed May 12, 2022 22:26 UTC |
Sanford Bart BenEVP, Operations
|
GrantRestricted Stock Unit · Derivative | 12,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028626 · doc4.xml · derivative · entry 1 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,680 Underlying: Common Stock · 12,680 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. F2 · derivative.expiration_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. Read SEC document |
| May 10, 2022 Filed May 12, 2022 22:24 UTC |
Glezer StanislavEVP, Chief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 32,638 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-028624 · doc4.xml · derivative · entry 1 Glezer Stanislav · CIK 0001866861 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,638 Underlying: Common Stock · 32,638 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. F2 · derivative.expiration_date: Subject to the reporting person's continued service, one hundred percent (100%) of the restricted stock units shall vest on May 1, 2024. Read SEC document |
| March 22, 2022 Filed Mar 25, 2022 01:02 UTC |
Ladone Mary KayDirector
|
GrantCommon Stock | 459 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-021015 · doc4.xml · nonDerivative · entry 1 Ladone Mary Kay · CIK 0001760737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459 F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) May 10, 2022, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule. Read SEC document |
| March 22, 2022 Filed Mar 24, 2022 21:15 UTC |
Boehnlein Glenn SDirector
|
GrantCommon Stock | 459 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-021026 · doc4.xml · nonDerivative · entry 1 Boehnlein Glenn S · CIK 0001670936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459 F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) May 10, 2022, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule. Read SEC document |
| March 22, 2022 Filed Mar 25, 2022 01:08 UTC |
King Kevin MDirector
|
GrantCommon Stock | 459 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-021020 · doc4.xml · nonDerivative · entry 1 King Kevin M · CIK 0001385014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459 F1 · shares: The reported shares wee acquired pursuant to a restricted stock unit award, which shall vest on the earlier of (i) May 10, 2022, or (ii) the day prior to the date of the Annual Meeting of the Issuer's stockholders next following the date of grant, in each case, subject to the reporting person continuing to be a service provider through the applicable vesting schedule. Read SEC document |
| March 21, 2022 Filed Mar 22, 2022 16:27 UTC |
Caltrider Kristin A.EVP, CFO and Treasurer
|
GrantRestricted Stock Unit · Derivative | 34,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-020531 · doc4.xml · derivative · entry 1 Caltrider Kristin A. · CIK 0001915385 · EVP, CFO and Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,081 Underlying: Common Stock · 34,081 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| March 03, 2022 Filed Mar 7, 2022 23:57 UTC |
Anderson Ray Benjamin MDirector
|
SaleCommon Stock | 4,516 | $34.68 | $156,618.94 |
DisclosureSEC source: 0001209191-22-016841 · doc4.xml · nonDerivative · entry 2 Anderson Ray Benjamin M · CIK 0001331802 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Trust Disclosed balance after: 0 F1 · price: Represents the weighted average share price of an aggregate total of 4,516 shares sold in the price range of $34.30 to $35.06 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · ownership.nature: Shares sold by the Benjamin M. Anderson-Ray Revocable Living Trust (the "Trust"), a trust for the benefit of the Reporting Person and his spouse, and for which the Reporting Person has shared voting and investment power with respect to the shares held by the Trust. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:55 UTC |
Somer JasonEVP, Gen. Counsel & Secretary
|
GrantRestricted Stock Unit · Derivative | 5,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016021 · doc4.xml · derivative · entry 1 Somer Jason · CIK 0001868735 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,680 Underlying: Common Stock · 5,680 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. F2 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:55 UTC |
Sanford Bart BenEVP, Operations
|
GrantRestricted Stock Unit · Derivative | 5,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016018 · doc4.xml · derivative · entry 11 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,680 Underlying: Common Stock · 5,680 shares Expires not disclosed F8 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F11 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. F11 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on March 1, 2023, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:55 UTC |
Sanford Bart BenEVP, Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 941 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016018 · doc4.xml · derivative · entry 10 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,822 Underlying: Common Stock · 941 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F10 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F10 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:55 UTC |
Sanford Bart BenEVP, Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 273 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016018 · doc4.xml · derivative · entry 9 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,184 Underlying: Common Stock · 273 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F9 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F9 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:55 UTC |
Sanford Bart BenEVP, Operations
|
Tax withholdingCommon Stock | 675 | $35.21 | $23,766.75 |
DisclosureSEC source: 0001209191-22-016018 · doc4.xml · nonDerivative · entry 8 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,826 F7 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:55 UTC |
Sanford Bart BenEVP, Operations
|
Exercise / conversionCommon Stock | 1,214 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016018 · doc4.xml · nonDerivative · entry 7 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,501 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:55 UTC |
Sanford Bart BenEVP, Operations
|
Tax withholdingCommon Stock | 737 | $35.21 | $25,949.77 |
DisclosureSEC source: 0001209191-22-016018 · doc4.xml · nonDerivative · entry 6 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,287 F6 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2021 performance-based restricted stock award granted on March 1, 2021 and vested on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:55 UTC |
Sanford Bart BenEVP, Operations
|
GrantCommon Stock | 1,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016018 · doc4.xml · nonDerivative · entry 5 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,024 F5 · shares: The reported securities represent shares earned and vested on March 1, 2022 based on achievement of the financial performance conditions for the 2021 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on March 1, 2021. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:55 UTC |
Sanford Bart BenEVP, Operations
|
Tax withholdingCommon Stock | 911 | $35.21 | $32,076.31 |
DisclosureSEC source: 0001209191-22-016018 · doc4.xml · nonDerivative · entry 4 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,143 F4 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2020 performance-based restricted stock award granted on March 1, 2020 and vested on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:55 UTC |
Sanford Bart BenEVP, Operations
|
GrantCommon Stock | 2,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016018 · doc4.xml · nonDerivative · entry 3 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,054 F3 · shares: The reported securities represent shares earned and vested on March 1, 2022 based on achievement of the financial performance conditions for the 2021 fiscal year that were approved as part of the 2020 performance-based restricted stock award granted on March 1, 2020. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:55 UTC |
Sanford Bart BenEVP, Operations
|
Tax withholdingCommon Stock | 644 | $35.21 | $22,675.24 |
DisclosureSEC source: 0001209191-22-016018 · doc4.xml · nonDerivative · entry 2 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,870 F2 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with the 2019 performance-based restricted stock award granted on March 1, 2019 and vested on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:55 UTC |
Sanford Bart BenEVP, Operations
|
GrantCommon Stock | 1,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016018 · doc4.xml · nonDerivative · entry 1 Sanford Bart Ben · CIK 0001751365 · EVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,514 F1 · shares: The reported securities represent shares earned and vested on March 1, 2022 based on achievement of the financial performance conditions for the 2021 fiscal year that were approved as part of the 2019 performance-based restricted stock award granted on March 1, 2019. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:54 UTC |
Glezer StanislavEVP, Chief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 11,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-016017 · doc4.xml · derivative · entry 2 Glezer Stanislav · CIK 0001866861 · EVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,360 Underlying: Common Stock · 11,360 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest on December 1, 2022, and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the vesting commencement date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.